-
Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes
Vermeire, S. V., Hanzel, J., Löwenberg, M., Ferrante, M., Bossuyt, P., Hoentjen, F., Franchimont, D., Palatka, K. R., Peeters, H., Mookhoek, A., de Hertogh, G., Molnár, T., van Moerkercke, W., Lobatón, T., Clasquin, E., Hulshoff, M. S. & on behalf of the LOVE-UC study group, 1 Apr 2024, In: Journal of Crohn's and Colitis. 18, 4, p. 540-547 8 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Efficacious dosing regimens for anti-TNF therapies in inflammatory bowel disease: where do we stand?
Anjie, S. I., Hulshoff, M. S. & D’Haens, G., 2023, In: Expert Opinion on Biological Therapy. 23, 4, p. 341-351 11 p.Research output: Contribution to journal › Review article › Academic › peer-review
-
Emerging therapies for ulcerative colitis
Hanzel, J., Hulshoff, M. S., Grootjans, J. & D’Haens, G., 2022, In: Expert review of clinical immunology. 18, 5, p. 513-524 12 p.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications
